Anti-Human CD30 (Brentuximab vedotin)
Product Specifications
Expression System
CHO
Reactivity
Human
Target
CD30
Clone
Brentuximab
Conjugation
Conjugated with monomethyl auristatin E (MMAE), via a cleavable maleimidocaproyl-valyl-citrullinyl-p-aminobenzyloxycarbonyl (mc-val-cit-PABC) type linker on an average of 4 cysteinyl
Purification
Protein A
Endotoxin
<1EU/mg Determined by LAL gel clotting assay
Purity
>95% Determined by SDS-PAGE
Buffer
ABDB-1002 or PBS, pH 7.4, Contains no stabilizers or preservatives.
Storage Conditions
The product need to be stored at the original stock concentration at 4°C.Avoid freeze / thaw cycle.
Formulation
PBS, pH 7.4, Contains no stabilizers or preservatives
Isotype Control
Human IgG1 (K214R) kappa-VcMMAE, ADC-Control
Sterility
0.2 μM filtered
Control Catalog Number
B23606407
Isotype
Human IgG1 (E356D/M358L) -kappa
Available Sizes
More Discoveries
Explore Other Products
Browse additional items from our catalog
MBS1002768-01 0.02 mg (E-Coli)
Recombinant Mycoplasma genitalium Putative serine/threonine-protein kinase (MG109)
Sign In for Pricing
View Details 
MBS1002768-02 0.02 mg (Yeast)
Recombinant Mycoplasma genitalium Putative serine/threonine-protein kinase (MG109)
Sign In for Pricing
View Details MBS1002768-03 0.1 mg (E-Coli)
Recombinant Mycoplasma genitalium Putative serine/threonine-protein kinase (MG109)
Sign In for Pricing
View Details MBS1002768-04 0.1 mg (Yeast)
Recombinant Mycoplasma genitalium Putative serine/threonine-protein kinase (MG109)
Sign In for Pricing
View Details 
MBS1002768-05 0.02 mg (Baculovirus)
Recombinant Mycoplasma genitalium Putative serine/threonine-protein kinase (MG109)
Sign In for Pricing
View Details MBS1002768-06 0.02 mg (Mammalian-Cell)
Recombinant Mycoplasma genitalium Putative serine/threonine-protein kinase (MG109)
Sign In for Pricing
View Details